China Medicine Corporation
Symbol: CHME
PNK
0.028
USDTrhová cena dnes
0.0009
Pomer P/E
-0.0001
Pomer PEG
79.67M
MRK Cap
- 0.00%
Výnos DIV
China Medicine Corporation (CHME) Finančné výkazy
Súvaha
common:word.in-mln USD Growth | TTM | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |||
---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 0.5 | 2.8 | 5.8 | ||||||
balance-sheet.row.short-term-investments | 0 | 0 | 0 | 0 | ||||||
balance-sheet.row.net-receivables | 0 | 22.3 | 19.8 | 13.6 | ||||||
balance-sheet.row.inventory | 0 | 2.7 | 4.7 | 3.9 | ||||||
balance-sheet.row.other-current-assets | 0 | 0.5 | 6.3 | 6.1 | ||||||
balance-sheet.row.total-current-assets | 0 | 30.3 | 33.7 | 29.4 | ||||||
balance-sheet.row.property-plant-equipment-net | 0 | 12 | 3.8 | 1.4 | ||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | ||||||
balance-sheet.row.intangible-assets | 0 | 16.7 | 1.2 | 1.2 | ||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 16.7 | 1.2 | 1.2 | ||||||
balance-sheet.row.long-term-investments | 0 | 7.9 | 0 | 0 | ||||||
balance-sheet.row.tax-assets | 0 | 0 | 0 | 0 | ||||||
balance-sheet.row.other-non-current-assets | 0 | 0 | 6 | 0.7 | ||||||
balance-sheet.row.total-non-current-assets | 0 | 36.6 | 11 | 3.2 | ||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||
balance-sheet.row.total-assets | 0 | 66.8 | 44.7 | 32.6 | ||||||
balance-sheet.row.account-payables | 0 | 1.3 | 0.1 | 0 | ||||||
balance-sheet.row.short-term-debt | 0 | 9.5 | 0 | 0 | ||||||
balance-sheet.row.tax-payables | 0 | 2.1 | 0.8 | 0 | ||||||
balance-sheet.row.long-term-debt-total | 0 | 0 | 0 | 0 | ||||||
Deferred Revenue Non Current | 0 | 0 | 0 | 0 | ||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | ||||||
balance-sheet.row.other-current-liab | 0 | 0.5 | 1 | 0.9 | ||||||
balance-sheet.row.total-non-current-liabilities | 0 | 6.9 | 0 | 0 | ||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||
balance-sheet.row.capital-lease-obligations | 0 | 0 | 0 | 0 | ||||||
balance-sheet.row.total-liab | 0 | 21.3 | 1.1 | 0.9 | ||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||
balance-sheet.row.common-stock | 0 | 0 | 0 | 0 | ||||||
balance-sheet.row.retained-earnings | 0 | 22.9 | 22.1 | 14 | ||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 4.4 | 4.4 | 4.3 | ||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 17.7 | 16.2 | 12.6 | ||||||
balance-sheet.row.total-stockholders-equity | 0 | 45 | 42.8 | 30.9 | ||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 66.8 | 44.7 | 32.6 | ||||||
balance-sheet.row.minority-interest | 0 | 0.5 | 0.8 | 0.9 | ||||||
balance-sheet.row.total-equity | 0 | 45.5 | 43.6 | 31.8 | ||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | ||||||
Total Investments | 0 | 7.9 | 0 | 0 | ||||||
balance-sheet.row.total-debt | 0 | 9.5 | 0 | 0 | ||||||
balance-sheet.row.net-debt | 0 | 9 | -2.8 | -5.8 |
Výkaz peňažných tokov
common:word.in-mln USD Growth | TTM | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |||
---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 1.4 | 9.1 | 6.9 | ||||||
cash-flows.row.depreciation-and-amortization | 0 | 1 | 0.4 | 0.8 | ||||||
cash-flows.row.deferred-income-tax | 0 | 0 | 0 | 0 | ||||||
cash-flows.row.stock-based-compensation | 0 | 0.1 | 0.1 | 0 | ||||||
cash-flows.row.change-in-working-capital | 0 | 7.1 | -5.4 | -10.1 | ||||||
cash-flows.row.account-receivables | 0 | -2.3 | -4.8 | 0 | ||||||
cash-flows.row.inventory | 0 | 3.4 | -0.5 | -1.8 | ||||||
cash-flows.row.account-payables | 0 | 0.6 | 0 | 0 | ||||||
cash-flows.row.other-working-capital | 0 | 5.4 | -0.1 | -8.2 | ||||||
cash-flows.row.other-non-cash-items | 0 | 7.3 | -0.1 | 0.1 | ||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | ||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -3.7 | -2.7 | -0.4 | ||||||
cash-flows.row.acquisitions-net | 0 | -8 | 0 | 0 | ||||||
cash-flows.row.purchases-of-investments | 0 | 0 | -5.2 | 0 | ||||||
cash-flows.row.sales-maturities-of-investments | 0 | 0 | 0 | 0 | ||||||
cash-flows.row.other-investing-activites | 0 | -1.9 | 0 | 0 | ||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -13.5 | -7.9 | -0.4 | ||||||
cash-flows.row.debt-repayment | 0 | -10.6 | 0 | 0 | ||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 7.8 | ||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | ||||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | 0 | ||||||
cash-flows.row.other-financing-activites | 0 | 4.9 | 0.4 | 0 | ||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | -5.7 | 0.4 | 7.8 | ||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0 | 0.3 | 0.3 | ||||||
cash-flows.row.net-change-in-cash | 0 | -2.3 | -3 | 5.4 | ||||||
cash-flows.row.cash-at-end-of-period | 0 | 0.5 | 2.8 | 5.8 | ||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 2.8 | 5.8 | 0.4 | ||||||
cash-flows.row.operating-cash-flow | 0 | 17 | 4.2 | -2.3 | ||||||
cash-flows.row.capital-expenditure | 0 | -3.7 | -2.7 | -0.4 | ||||||
cash-flows.row.free-cash-flow | 0 | 13.3 | 1.5 | -2.7 |
Riadok výkazu ziskov a strát
common:word.in-mln USD Growth | TTM | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |||
---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 64.8 | 53.6 | 42.1 | ||||||
income-statement-row.row.cost-of-revenue | 0 | 45.8 | 38.1 | 29.7 | ||||||
income-statement-row.row.gross-profit | 0 | 19 | 15.6 | 12.4 | ||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||
income-statement-row.row.research-development | 0 | - | - | - | ||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | ||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||
income-statement-row.row.other-expenses | 0 | 0 | 0 | 0 | ||||||
income-statement-row.row.operating-expenses | 0 | 6.7 | 4.6 | 4 | ||||||
income-statement-row.row.cost-and-expenses | 0 | 52.5 | 42.7 | 33.7 | ||||||
income-statement-row.row.interest-income | 0 | 0 | 0 | 0 | ||||||
income-statement-row.row.interest-expense | 0 | 0 | 0 | 0 | ||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||
income-statement-row.row.total-other-income-expensenet | 0 | -7.3 | 0.1 | 0 | ||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||
income-statement-row.row.other-operating-expenses | 0 | 0 | 0 | 0 | ||||||
income-statement-row.row.total-operating-expenses | 0 | -7.3 | 0.1 | 0 | ||||||
income-statement-row.row.interest-expense | 0 | 0 | 0 | 0 | ||||||
income-statement-row.row.depreciation-and-amortization | 0 | 1 | 0.4 | 0.8 | ||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | ||||||
income-statement-row.row.operating-income | 0 | 12.3 | 10.9 | 8.4 | ||||||
income-statement-row.row.income-before-tax | 0 | 5 | 11 | 8.4 | ||||||
income-statement-row.row.income-tax-expense | 0 | 3.5 | 2 | 1.6 | ||||||
income-statement-row.row.net-income | 0 | 1.7 | 9.1 | 6.9 |
Často kladené otázky
Čo je China Medicine Corporation (CHME) celkové aktíva?
China Medicine Corporation (CHME) celkové aktíva sú 66844482.000.
Aký je ročný obrat podniku?
Ročné príjmy sú N/A.
Aké je ziskové rozpätie podniku?
Zisková marža firmy je 0.293.
Aký je voľný peňažný tok podniku?
Voľný peňažný tok je 0.870.
Aká je čistá zisková marža podniku?
Čistá zisková marža je 0.027.
Aké sú celkové výnosy podniku?
Celkové príjmy sú 0.189.
Aká je China Medicine Corporation (CHME) čistý zisk (čistý príjem)?
Čistý zisk (čistý príjem) je 1717677.000.
Aký je celkový dlh firmy?
Celkový dlh je 9506160.000.
Aké je číslo prevádzkových nákladov?
Prevádzkové výdavky sú 6718099.000.
Aký je údaj o hotovosti spoločnosti?
Peňažné prostriedky podniku sú 0.000.